Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study.
Hematol Oncol
; 41(3): 574-577, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-36218059
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Waldenstrom Macroglobulinemia
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Year:
2023
Type:
Article